Collectively, these results demonstrated that via its m6A binding sites, LOXL3 not only had an oncogenic role in the migration and invasion of melanoma but served as an important ‘executor’ of YTHDF3 (Figure 9). The gene discussed is LOXL3; the disease is melanoma.